Through disrupting the exonic splicing silencer, it can increase skipping of IL7R exon 6 to produce more soluble and membrane-bound isoforms of IL7R protein (IL7Ra), which is a key factor in the immune response pathway of MS (Gregory et al., 2007). The gene discussed is IL7R; the disease is myeloid sarcoma.